Literature DB >> 34881984

Near-Complete Genome Sequencing of Influenza C Virus in the Philippines between 2014 and 2019.

Daisetsu Fujita1, Clyde Dapat1, Emmanuel Kagning Tsinda1, Mayuko Saito1, Michiko Okamoto1, Mariko Saito-Obata1, Beatriz P Quiambao2, Socorro P Lupisan2, Hitoshi Oshitani1.   

Abstract

We report 19 nearly complete genome sequences of influenza C virus isolated from clinical samples recovered from children in the Philippines between 2014 and 2019.

Entities:  

Year:  2021        PMID: 34881984      PMCID: PMC8656392          DOI: 10.1128/MRA.00900-21

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


ANNOUNCEMENT

Influenza C virus (ICV), a member of the Orthomyxoviridae family, consists of an antisense single-stranded RNA genome in seven segments: polymerase basic 2 (PB2), polymerase basic 1 (PB1), polymerase 3 (P3), hemagglutinin-esterase (HE), nucleoprotein (NP), matrix (M), and nonstructural (NS). HE protein determines the antigenic properties of ICV, and currently, there are six different lineages (1). ICV mainly causes mild upper respiratory tract illnesses in children. However, sometimes it also causes lower respiratory tract illnesses, such as bronchitis, bronchiolitis, and pneumonia (2–5). ICV has been recognized as a common respiratory pathogen in humans (6–10). In our previous study, we analyzed ICV strains isolated between 2009 and 2013 in the Philippines. We determined the complete sequences of coding regions (CDS) of the HE, M, and NS gene segments and partial sequences of the four internal gene segments; we observed that the composition of the internal genes of the Philippines strains differed from that of Japanese strains (11). In this study, we aimed to determine the complete genome sequences of all seven gene segments of ICV in children in the Philippines between 2014 and 2019. The study was approved by the Ethics Committee of Tohoku University Graduate School of Medicine, Japan, and the Institutional Review Board of the RITM, Philippines. We conducted a cohort study on Biliran Island from 2014 to 2019 and collected nasal or nasopharyngeal swabs from children with acute respiratory illness (12). We also collected samples from hospitalized children with severe pneumonia in a hospital-based study on Palawan Island from 2014 to 2016 (13). ICV was isolated and propagated in Madin–Darby canine kidney cell culture using a microplate method (11, 14), and total RNA in the cell culture supernatant was extracted using a QIAamp viral RNA minikit (Qiagen, Hilden, Germany). DNA libraries were generated using the TruSeq stranded mRNA LT sample prep kit and sequenced (100-bp paired-end reads) on a NovaSeq 6000 S4 flow cell on the Illumina NovaSeq 6000 platform at Macrogen Japan Corporation (Tokyo, Japan). CLC Genomics Workbench version 20.0.4 (Qiagen, Hilden, Germany) was used for data analysis. Quality control of the raw reads, including removal of adapter sequence and low-quality reads, was performed using the default settings of CLC Workbench. Consensus sequences were extracted from the mapped reads after simultaneous mapping of the reads to the following reference sequences: GenBank accession number NC_006307 for PB2, NC_006308 for PB1, NC_006309 for P3, NC_006310 for HE, NC_006311 for NP, NC_006312 for M, and NC_006306 for NS. The average coverage per sample ranged from 5,390 to 152,413 reads (Table 1). The minimum and maximum depths of coverage in the CDS of all samples were 143 and 551,997 reads, respectively. The full length of the CDS was covered at more than 100× depth. Based on a phylogenetic analysis of the HE gene, the samples were divided into two lineages: C/Kanagawa and C/Sao Paulo (Fig. 1).
TABLE 1

Information on complete genome sequences of influenza C virus

StrainYrNo. of reads% GCAvg coverage (×)% of coding regions covered at ≥100×Sequence Read Archive accession no.GenBank accession no.Gene length (bp)
PB2PB1P3HENPMNS
C/Palawan/068/2014201444,582,78652.3562,20594.47 SRR14537525 MZ331007MZ3310132,3252,2652,1301,9681,6981,125862
C/Biliran/TB5-195/2014201443,211,15054.4113,91694.39 SRR14537524 MZ330944MZ3309502,3252,2652,1301,9681,6981,125862
C/Biliran/TB5-241/2014201453,471,66453.6934,39394.47 SRR14537514 MZ330951MZ3309572,3252,2652,1301,9681,6981,125862
C/Biliran/TB2-162/2014201457,572,61855.409,97894.41 SRR14537513 MZ330881MZ3308872,3252,2652,1301,9681,6981,125862
C/Biliran/TB2-180/2014201448,560,15254.765,39094.40 SRR14537512 MZ330888MZ3308942,3252,2652,1301,9681,6981,125862
C/Biliran/TB8-250/2014201449,854,39454.5520,15394.37 SRR14537511 MZ330993MZ3309992,3252,2652,1301,9681,6981,125862
C/Biliran/TB2-204/2014201452,851,94253.3518,79394.51 SRR14537510 MZ330895MZ3309012,3252,2652,1301,9681,6981,125862
C/Biliran/TB2-293/2014201445,432,86053.4920,27794.39 SRR14537509 MZ330902MZ3309082,3252,2652,1301,9681,6981,125862
C/Palawan/061/2015201544,671,64653.5731,77094.46 SRR14537508 MZ331000MZ3310062,3252,2652,1301,9681,6981,125862
C/Biliran/TB5-498/2016201661,000,69654.2763,61694.45 SRR14537507 MZ330965MZ3309712,3252,2652,1301,9681,6981,125862
C/Biliran/TB5-536/2016201662,519,48252.7181,83494.42 SRR14537523 MZ330972MZ3309782,3252,2652,1301,9681,6981,125862
C/Biliran/TB5-625/2016201657,831,76049.51100,70894.52 SRR14537522 MZ330979MZ3309852,3252,2652,1301,9681,6981,125862
C/Biliran/TB5-736/2016201648,786,38453.5938,65494.51 SRR14537521 MZ330986MZ3309922,3252,2652,1301,9681,6981,125862
C/Biliran/TB4-024/2017201762,691,49452.8488,60894.55 SRR14537520 MZ330909MZ3309152,3252,2652,1301,9681,6981,125862
C/Biliran/TB5-312/2017201762,459,36854.8460,85794.47 SRR14537519 MZ330958MZ3309642,3252,2652,1301,9681,6981,125862
C/Biliran/TB4-067/2017201762,583,13255.0147,90794.48 SRR14537518 MZ330916MZ3309222,3252,2652,1301,9681,6981,125862
C/Biliran/TB4-130/2018201842,157,53451.5979,84794.48 SRR14537517 MZ330923MZ3309292,3252,2652,1301,9681,6981,125862
C/Biliran/TB4-169/2018201849,578,33849.16152,41394.58 SRR14537516 MZ330930MZ3309362,3252,2652,1301,9681,6981,125862
C/Biliran/TB4-271/2019201947,001,39456.2510,68794.50 SRR14537515 MZ330937MZ3309432,3252,2652,1301,9681,6981,125862

The average coverage and percentage of coding regions covered at ≥100× were calculated for the complete sequence of the coding regions as follows: nucleotides 22 to 2346 for polymerase basic 2 (PB2), nucleotides 18 to 2282 for polymerase basic 1 (PB1), nucleotides 22 to 2151 for polymerase 3 (P3), nucleotides 22 to 1989 for hemagglutinin-esterase (HE), nucleotides 30 to 1727 for nucleoprotein (NP), nucleotides 26 to 1150 for matrix (M), and nucleotides 27 to 888 for the nonstructural (NS) gene.

FIG 1

Phylogenetic tree of the influenza C virus hemagglutinin-esterase (HE) gene. For this analysis, the length of the coding region of the HE gene was 1,926 nucleotides (positions 64 to 1989). The phylogenetic tree was constructed using the neighbor-joining method in MEGA7 software, using T92 as the substitution model with gamma-distributed site heterogeneity. The bootstrap values were calculated from 1,000 replicates, and values greater than 75% are shown at the branches of the tree. Strains analyzed in this study are marked with circles: green circles for lineage C/Kanagawa and red circles for lineage C/Sao Paulo.

Phylogenetic tree of the influenza C virus hemagglutinin-esterase (HE) gene. For this analysis, the length of the coding region of the HE gene was 1,926 nucleotides (positions 64 to 1989). The phylogenetic tree was constructed using the neighbor-joining method in MEGA7 software, using T92 as the substitution model with gamma-distributed site heterogeneity. The bootstrap values were calculated from 1,000 replicates, and values greater than 75% are shown at the branches of the tree. Strains analyzed in this study are marked with circles: green circles for lineage C/Kanagawa and red circles for lineage C/Sao Paulo. Information on complete genome sequences of influenza C virus The average coverage and percentage of coding regions covered at ≥100× were calculated for the complete sequence of the coding regions as follows: nucleotides 22 to 2346 for polymerase basic 2 (PB2), nucleotides 18 to 2282 for polymerase basic 1 (PB1), nucleotides 22 to 2151 for polymerase 3 (P3), nucleotides 22 to 1989 for hemagglutinin-esterase (HE), nucleotides 30 to 1727 for nucleoprotein (NP), nucleotides 26 to 1150 for matrix (M), and nucleotides 27 to 888 for the nonstructural (NS) gene. These nearly complete genome sequences reveal the ICV lineages that circulated between 2014 and 2019 in the Philippines.

Data availability.

The nearly complete genome sequences of 19 ICV isolates have been deposited in GenBank (accession numbers MZ330881 to MZ331013). The raw sequencing reads were deposited in the NCBI Sequence Read Archive under BioProject accession number PRJNA719209.
  14 in total

1.  Influenza C virus infection in military recruits--symptoms and clinical manifestation.

Authors:  Jaana Kauppila; Esa Rönkkö; Raija Juvonen; Annika Saukkoriipi; Pekka Saikku; Aini Bloigu; Olli Vainio; Thedi Ziegler
Journal:  J Med Virol       Date:  2013-09-30       Impact factor: 2.327

2.  Isolation and characterization of influenza C viruses in the Philippines and Japan.

Authors:  Takashi Odagiri; Yoko Matsuzaki; Michiko Okamoto; Akira Suzuki; Mariko Saito; Raita Tamaki; Socorro P Lupisan; Lydia T Sombrero; Seiji Hongo; Hitoshi Oshitani
Journal:  J Clin Microbiol       Date:  2014-12-31       Impact factor: 5.948

3.  Epidemiological information regarding the periodic epidemics of influenza C virus in Japan (1996-2013) and the seroprevalence of antibodies to different antigenic groups.

Authors:  Yoko Matsuzaki; Kanetsu Sugawara; Chieko Abiko; Tatsuya Ikeda; Yoko Aoki; Katsumi Mizuta; Noriko Katsushima; Fumio Katsushima; Yuriko Katsushima; Tsutomu Itagaki; Yoshitaka Shimotai; Seiji Hongo; Yasushi Muraki; Hidekazu Nishimura
Journal:  J Clin Virol       Date:  2014-06-28       Impact factor: 3.168

4.  A novel real-time RT-PCR assay for influenza C tested in Peruvian children.

Authors:  Leigh M Howard; Monika Johnson; Ana I Gil; Andrew Pekosz; Marie R Griffin; Kathryn M Edwards; Claudio F Lanata; Carlos G Grijalva; John V Williams
Journal:  J Clin Virol       Date:  2017-09-01       Impact factor: 3.168

5.  Aetiology and risks factors associated with the fatal outcomes of childhood pneumonia among hospitalised children in the Philippines from 2008 to 2016: a case series study.

Authors:  Bindongo Price Polycarpe Dembele; Taro Kamigaki; Clyde Dapat; Raita Tamaki; Mariko Saito; Mayuko Saito; Michiko Okamoto; Mary Ann U Igoy; Edelwisa Segubre Mercado; Melisa Mondoy; Veronica L Tallo; Socorro P Lupisan; Shinichi Egawa; Hitoshi Oshitani
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

6.  Identification of influenza C virus in young South Korean children, from October 2013 to September 2016.

Authors:  Han Sol Lee; Sooyeon Lim; Ji Yun Noh; Joon Young Song; Hee Jin Cheong; Jung Hwa Lee; Sung Il Woo; Woo Joo Kim
Journal:  J Clin Virol       Date:  2019-03-27       Impact factor: 3.168

7.  Influenza C virus–associated community-acquired pneumonia in children.

Authors:  Nicola Principi; Alessia Scala; Cristina Daleno; Susanna Esposito
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

8.  Influenza C infections in Western Australia and Victoria from 2008 to 2014.

Authors:  Lauren Jelley; Avram Levy; Yi-Mo Deng; Natalie Spirason; Jurissa Lang; Iwona Buettner; Julian Druce; Chris Blyth; Paul Effler; David Smith; Ian G Barr
Journal:  Influenza Other Respir Viruses       Date:  2016-07-23       Impact factor: 4.380

9.  Association Between Preceding Viral Respiratory Infection and Subsequent Respiratory Illnesses Among Children: A Prospective Cohort Study in the Philippines.

Authors:  Yuki Furuse; Raita Tamaki; Michiko Okamoto; Mariko Saito-Obata; Akira Suzuki; Mayuko Saito; Tadatsugu Imamura; Irona Khandaker; Isolde Dapat; Fumihiko Ueno; Portia Parian Alday; Alvin Gue Tan; Marianette Tawat Inobaya; Edelwisa Segubre-Mercado; Veronica Tallo; Socorro Lupisan; Hitoshi Oshitani
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

10.  Study of influenza C virus infection in France.

Authors:  S Gouarin; A Vabret; J Dina; J Petitjean; J Brouard; D Cuvillon-Nimal; F Freymuth
Journal:  J Med Virol       Date:  2008-08       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.